Get the Stockscreener App
11.95
2.31%
0.27
Pre-market:
12.18
0.23
+1.92%
Assertio Holdings Inc stock is traded at $11.95, with a volume of 16,987.
It is up +2.31% in the last 24 hours and up +30.03% over the past month.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
See More
Previous Close:
$11.68
Open:
$11.63
24h Volume:
16,987
Relative Volume:
0.33
Market Cap:
$76.68M
Revenue:
$169.43M
Net Income/Loss:
$-186.01M
P/E Ratio:
-5.9158
EPS:
-2.02
Net Cash Flow:
$70.07M
1W Performance:
+0.84%
1M Performance:
+30.03%
6M Performance:
+9.89%
1Y Performance:
-7.13%
1-Day Range:
$11.60
$11.99
1-Week Range:
$11.43
$12.95
52-Week Range:
$7.7055
$15.15
Assertio Holdings Inc Stock (ASRT) Company Profile
Name
Assertio Holdings Inc
Sector
Phone
(224) 419-7106
Address
100 S. SAUNDERS ROAD, LAKE FOREST, IL
Compare ASRT vs TAK, ZTS, HLN, TEVA, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ASRT
Assertio Holdings Inc
|
11.95 | 74.95M | 169.43M | -186.01M | 70.07M | -2.02 |
|
TAK
Takeda Pharmaceutical Co Adr
|
18.28 | 57.18B | 29.85B | 776.90M | 4.35B | 0.2408 |
|
ZTS
Zoetis Inc
|
128.67 | 56.47B | 9.40B | 2.65B | 2.24B | 5.935 |
|
HLN
Haleon Plc Adr
|
11.16 | 49.16B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
34.31 | 40.03B | 17.41B | 1.43B | 1.00B | 1.2182 |
|
UTHR
United Therapeutics Corp
|
475.85 | 20.37B | 3.13B | 1.27B | 1.12B | 26.39 |
Assertio Holdings Inc Stock (ASRT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-26-24 | Initiated | Maxim Group | Buy |
| Jul-03-24 | Initiated | H.C. Wainwright | Buy |
| Nov-07-22 | Initiated | Lake Street | Buy |
| Nov-30-18 | Downgrade | Mizuho | Buy → Neutral |
Assertio Holdings Inc Stock (ASRT) Latest News
US Market Wrap: Can Assertio Holdings Inc maintain sales growthTrade Exit Summary & Safe Capital Preservation Plans - baoquankhu1.vn
Why Assertio Holdings Inc. stock is rated strong buyGap Down & Long-Term Safe Investment Ideas - mfd.ru
Value Recap: Is Assertio Holdings Inc a strong candidate for buy and hold2025 Pullback Review & Weekly High Potential Stock Alerts - baoquankhu1.vn
Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry - simplywall.st
What Could Shift The Assertio Holdings ASRT Narrative After Recent Updates And Peer Signals - Yahoo Finance
Assertio (NASDAQ:ASRT) Stock Price Up 3.9%Here's What Happened - MarketBeat
Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High? - Finviz
There's No Escaping Assertio Holdings, Inc.'s (NASDAQ:ASRT) Muted Revenues Despite A 28% Share Price Rise - 富途牛牛
Can Assertio Holdings Inc. maintain sales growthWeekly Profit Recap & Capital Protection Trading Alerts - mfd.ru
Pullback Watch: Is Assertio Holdings Inc stock risky to hold now2025 Key Lessons & Safe Swing Trade Setups - baoquankhu1.vn
Pullback Watch: Does Assertio Holdings Inc have declining or rising EPSMarket Growth Review & Daily Volume Surge Signals - baoquankhu1.vn
Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet - sharewise.com
Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - sharewise.com
Assertio regains nasdaq compliance after successful reverse split By Investing.com - Investing.com Nigeria
Assertio regains compliance with Nasdaq minimum bid price requirement - Investing.com India
Short Interest in Assertio Holdings, Inc. (NASDAQ:ASRT) Decreases By 92.8% - MarketBeat
Assertio Therapeutics announces 1-for-15 reverse stock split - MSN
Assertio regains compliance with Nasdaq minimum bid price requirement By Investing.com - Investing.com Nigeria
Assertio regains Nasdaq compliance after bid price recovery - MSN
Assertio regains nasdaq compliance after successful reverse split - Investing.com
Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - The Joplin Globe
Los Angeles Daily NewsAssertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements - FinancialContent
How Recent Valuation Reset And Leadership Changes Are Reframing The Assertio Holdings (ASRT) Story - Yahoo Finance
Assertio Reports Positive Clinical Trial Results for Rolvedon with Same-Day Dosing - Intellectia AI
Assertio Announces Publication of Rolvedon® Same-Day Dosing Clinical Trial - The Joplin Globe
Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan
Why Assertio Holdings Inc. stock is trending among retail traders2025 Investor Takeaways & AI Forecast Swing Trade Picks - Улправда
Why Assertio Holdings Inc. stock remains a top recommendationForecast Cut & Real-Time Sentiment Analysis - Улправда
What momentum indicators show for Assertio Holdings Inc. stockJuly 2025 Intraday Action & Trade Opportunity Analysis Reports - Улправда
FY2025 EPS Estimates for Assertio Raised by HC Wainwright - Defense World
FY2025 EPS Estimates for Assertio Increased by HC Wainwright - MarketBeat
HC Wainwright Forecasts Assertio’s Q4 Earnings (NASDAQ:ASRT) - Defense World
What is HC Wainwright's Forecast for Assertio Q4 Earnings? - MarketBeat
Support Test: Can Assertio Holdings Inc stock deliver 10 annual returnsMarket Performance Recap & Weekly Watchlist of Top Performers - moha.gov.vn
H.C. Wainwright raises Assertio stock price target to $35 following reverse split - Investing.com Canada
H.C. Wainwright raises Assertio stock price target to $35 following reverse split By Investing.com - Investing.com South Africa
Assertio (NASDAQ:ASRT) Upgraded at Zacks Research - Defense World
Analysts’ Top Healthcare Picks: Assertio Therapeutics (ASRT), REPRO-MED Systems (KRMD) - The Globe and Mail
Assertio (NASDAQ:ASRT) Raised to Strong-Buy at Zacks Research - MarketBeat
Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 - marketscreener.com
Assertio Holdings announces 1-for-15 reverse stock split - MSN
ASSERTIO HOLDINGS INC Financial Disclosures & Filings - TradingView — Track All Markets
Assertio Holdings Inc Stock (ASRT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Assertio Holdings Inc Stock (ASRT) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Schwichtenberg Paul | President and COO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
12,834 |
| Patel Ajay | EVP and CFO |
Feb 07 '26 |
Option Exercise |
0.00 |
1,666 |
0 |
14,789 |
| Stark David Matthew | Director |
Nov 10 '25 |
Sale |
0.76 |
8,959 |
6,806 |
98,541 |
1.21%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):